Recent advances in gastric ulcer therapeutics

Current Opinion in Pharmacology

Volumn 5, Issue 6 SPEC. ISS., 2005, Pages 573-577

  Wallace, John L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; ACETYLSALICYLIC ACID; ALENDRONIC ACID; ANNEXIN; ANTIBIOTIC AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ESOMEPRAZOLE; GLUCOCORTICOID; GROWTH FACTOR; HYDROCHLORIC ACID; INDOMETACIN; LEUKOTRIENE D4 RECEPTOR; LIPOXIN A; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROBIOTIC AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 4; PROTON PUMP INHIBITOR; ROFECOXIB; SERUM RESPONSE FACTOR; TICLOPIDINE; UNINDEXED DRUG; VALDECOXIB; VASCULOTROPIN;

ACID SECRETION; CARDIOVASCULAR DISEASE; CELLULAR DISTRIBUTION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG WITHDRAWAL; ENZYME ACTIVITY; ESOPHAGUS ULCER; GENE LOCATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PRIORITY JOURNAL; RARE DISEASE; REVIEW; SKIN DISEASE; STOMACH MUCOSA; STOMACH ULCER; THROMBOCYTE; ULCER HEALING;

EID: 27744463754     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2005.06.004     Document Type: Review

References (30)

1. A. Pilotto M. Franceschi G. Leandro F. Paremeris L. Cascavilla M.G. Longo V. Niro A. Andriulli C. Scarcelli F. Di Mario Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs Aliment Pharmacol Ther 20 2004 1091-1097
2. F.K. Chan J.Y. Ching L.C. Hung V.W. Wong V.K. Leung N.N. Kung A.J. Hui J.C. Wu W.K. Leung V.W. Lee et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding N Engl J Med 352 2005 238-244
3. L. Ma S.N. Elliott G. Cirino A. Buret L.J. Ignarro J.L. Wallace Platelets modulate gastric ulcer healing: Role of endostatin and vascular endothelial growth factor release Proc Natl Acad Sci USA 98 2001 6470-6475
4. J. Chai M.K. Jones A.S. Tarnawski Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis FASEB J 18 2004 1264-1266
5. N. Vergnolle J.L. Wallace N.W. Bunnett M.D. Hollenberg Protease-activated receptors in inflammation, neuronal signaling and pain Trends Pharmacol Sci 22 2001 146-152
6. L. Ma R. Perini W. McKnight M. Dicay A. Klein M.D. Hollenberg J.L. Wallace Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets Proc Natl Acad Sci USA 102 2005 216-220
7. S. Sanchez-Fidalgo I. Martin-Lacave M. Illanes V. Motilva Angiogenesis, cell proliferation and apoptosis in gastric ulcer healing. Effect of a selective cox-2 inhibitor Eur J Pharmacol 505 2004 187-194
8. L. Ma P. del Soldato J.L. Wallace Divergent effects of new cyclooxygenase inhibitors on gastric ulcer healing: Shifting the angiogenic balance Proc Natl Acad Sci USA 99 2002 13243-13247
9. N.M. Davies K.A. Sharkey S. Asfaha W.K. Macnaughton J.L. Wallace Aspirin causes rapid up-regulation of cyclo-oxygenase-2 expression in the stomach of rats Aliment Pharmacol Ther 11 1997 1101-1108
10. K. Takeuchi A. Tanaka Y. Hayashi Y. Kubo Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: Importance of gastric hypermotility Dig Dis Sci 49 2004 180-187
11. P. Bhandari A.C. Bateman R.L. Mehta P. Patel Mucosal expression of cyclooxygenase isoforms 1 and 2 is increased with worsening damage to the gastric mucosa Histopathology 46 2005 280-286
12. J.L. Wallace P.R. Devchand Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense Br J Pharmacol 145 2005 275-282
13. C.N. Serhan M. Arita S. Hong K. Gotlinger Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers Lipids 39 2004 1125-1132
14. 4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction Proc Natl Acad Sci USA 101 2004 15736-15741
15. M. Arita M. Yoshida S. Hong E. Tjonahen J.N. Glickman N.A. Petasis R.S. Blumberg C.N. Serhan Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis Proc Natl Acad Sci USA 102 2005 7671-7676
16. 4 increases gastric resistance to aspirin-induced damage Gastroenterology 123 2002 1598-1606
17. J.L. Wallace S.R. Zamuner W. McKnight M. Dicay A. Mencarelli P. del Soldato S. Fiorucci Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation Am J Physiol Gastrointest Liver Physiol 286 2004 G76-G81
18. S. Fiorucci L. Santucci J.L. Wallace M. Sardina M. Romano P. del Soldato A. Morelli Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa Proc Natl Acad Sci USA 100 2003 10937-10941
19. L. Laine E.S. Maller C. Yu H. Quan T. Simon Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: A double-blind trial Gastroenterology 127 2004 395-402
20. S. Fiorucci A. Di Lorenzo B. Renga S. Farneti A. Morelli G. Cirino Nitric oxide (NO)-releasing naproxen (HCT-3012 [(S)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid 4-(nitrooxy)butyl ester]) interactions with aspirin in gastric mucosa of arthritic rats reveal a role for aspirin-triggered lipoxin, prostaglandins, and NO in gastric protection J Pharmacol Exp Ther 311 2004 1264-1271
21. J.L. Wallace M.J. Miller Nitric oxide in mucosal defense: A little goes a long way Gastroenterology 119 2000 512-520
22. L. Laine Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs - nice or necessary? Rev Gastroenterol Disord 4 2004 S33-S41
23. K. Gudis A. Tatsuguchi K. Wada S. Futagami K. Nagata T. Hiratsuka Y. Shinji K. Miyake T. Tsukui Y. Fukuda C. Sakamoto Microsomal prostaglandin E synthase (mPGES)-1, mPGES-2 and cytosolic PGES expression in human gastritis and gastric ulcer tissue Lab Invest 85 2005 225-236
24. M. Perretti F.N. Gavins Annexin 1: An endogenous anti-inflammatory protein News Physiol Sci 18 2003 60-64
25. R.C. Zanardo M. Perretti J.L. Wallace Annexin-1 is an endogenous gastroprotective factor against indomethacin-induced damage Am J Physiol Gastrointest Liver Physiol 288 2005 G481-G486
26. J.K. Marshall The gastrointestinal tolerability and safety of oral bisphosphonates Expert Opin Drug Saf 1 2002 71-78
27. G. Sener C. Kapucu S. Cetinel E. Cikler G. Ayanoglu-Dulger Gastroprotective effect of leukotriene receptor blocker montelukast in alendronate-induced lesions of the rat gastric mucosa Prostaglandins Leukot Essent Fatty Acids 72 2005 1-11
28. S.N. Elliott A. Buret W. McKnight M.J. Miller J.L. Wallace Bacteria rapidly colonize and modulate healing of gastric ulcers in rats Am J Physiol 275 1998 G425-G432
29. S.N. Elliott J.L. Wallace W. McKnight D.G. Gall J.A. Hardin M. Olson A. Buret Bacterial colonization and healing of gastric ulcers: The effects of epidermal growth factor Am J Physiol Gastrointest Liver Physiol 278 2000 G105-G112
30. Uchida M, Kurakazu K: Yogurt containing Lactobacillus gasseri OLL2716 exerts gastroprotective action against [correction of agaisnt] acute gastric lesion and antral ulcer in rats. J Pharmacol Sci 2004, 96:84-90.